Unihealth Hospitals Ltd

Unihealth Hospitals Ltd

NNSE:UNIHEALTH
495.50
INR
+20.35
(+4.28%)
29.24EPS
21.74P/E
5.69BMarket Cap
Unihealth Hospitals Ltd
NSE:UNIHEALTH
(National Stock Exchange of India)

Recent

price

495.50

P/E

ratio

21.74

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
2026
INR
14.43
17.02
23.92
28.53
36.26
64.33
85.16
Revenue per Share
-0.55
3.25
2.48
4.99
7.67
9.17
16.67
Basic EPS, GAAP
-1.22
2.4
5.17
-0.64
1.71
-8.37
-16.47
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
3.69
6.95
9.61
17.87
56.15
65.82
87.65
Book Value per Share
-1.24
2.04
4.7
12.92
50.3
59.97
81.92
Tangible Book Value per Share
15
15
15
15
13
15
15
Basic Weighted Avg Shares
222
262
368
439
488
991
1,320
Sales/Revenue/Turnover
-0.25
16.54
25.23
25.31
31.62
31.12
33.04
Operating Margin (%)
22
22
22
25
23
60
102
Depreciation Expense
-8
50
38
77
103
141
258
Net Income, GAAP
- -
9.57
27.12
17.47
23.87
10.76
1.83
Effective Tax Rate (%)
-3.81
19.11
10.37
17.48
21.14
14.26
19.57
Profit Margin (%)
27
88
111
189
693
804
1,266
Working Capital
352
369
359
357
184
111
254
LT Debt
57
106
146
273
1,118
1,418
1,980
Total Equity
- -
8.35
13.45
15.06
11.21
17.93
21.57
Return on Invested Capital (%)
- -
12.34
14.81
18.32
11.8
2.63
4
Return on Capital (%)
- -
61.14
29.97
36.3
18.08
15.04
21.62
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

INR

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
100.26%
39.59%
Free Cash Flow
- -
-178.42%
98.14%
Net Income, GAAP
- -
46.29%
82.87%
Sales/Revenue/Turnover
- -
41.45%
33.23%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
488
2025
- -
- -
- -
- -
991
2026
- -
- -
- -
- -
1,320

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
7.67
2025
- -
- -
- -
- -
9.17
2026
- -
- -
- -
- -
16.67

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Unihealth Hospitals Ltd (UNIHEALTH.NS) is a diversified healthcare services provider operating hospitals, medical centers, and related businesses primarily in Africa and India. Founded in 2010 and headquartered in Mumbai, India, the company delivers multi-specialty hospital services under the UMC Hospitals brand, including general medicine and surgery; laparoscopic surgery; orthopedics and spine; neurology and neurosurgery; obstetrics and gynecology; pediatrics and neonatology; gastroenterology; comprehensive diagnostics and radiology; nephrology and urology; dermatology and cosmetology; intensive care; rehabilitative medicine; oncology; ENT; dental; and optometry. It also offers healthcare consultancy and project management services; exports and distributes pharmaceuticals, medical consumables, nutraceuticals, and medical equipment across African markets; and provides medical value travel facilitation for international patients. The company maintains operational facilities in Uganda, Tanzania, and previously Nigeria, with a combined capacity of approximately 200 beds, alongside consultancy for projects exceeding 1,300 beds in India and Africa. Geographic segments encompass India; Uganda; Tanzania; Nigeria; and the United Arab Emirates. Recent developments include the planned opening of its first Indian facility, a 52-bed UMC Hospital in Navi Mumbai, in October 2025, followed by expansions in Nashik, India, and a 20-bed UMC Health Center in Mwanza, Tanzania, by year-end 2025. In 2024, Unihealth Hospitals strengthened its presence through a partnership with North Coast Healthcare Solutions Limited in Kenya for design and consultancy services; its wholly-owned subsidiary Unihealth Holdings Limited, Mauritius, acquired a 53.33% equity stake in a target entity; and it increased its stake in UMC Global Health Limited (Nigeria) to 51% via a 1% acquisition for NGN 55.4 million. These initiatives support a Rs 125 crore investment plan across India and Africa for 2024-2026 to drive bed capacity growth and market consolidation.